Filing Flows › Rigel Pharmaceuticals (RIGL) › Recalls, complaints & regulation
Rigel Pharmaceuticals (RIGL): clinical trials
Rigel Pharmaceuticals (RIGL) beyond its filings: 5 active clinical trials.
Rigel Pharmaceuticals' latest quarter
Rigel Pharmaceuticals, Q3 2026: revenue $80.9M (+16% year over year), operating margin 21.1%, net earnings $13.2M, operating cash flow $34.6M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Rigel Pharmaceuticals have?
5 active studies on ClinicalTrials.gov, 1 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.